Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 2908
Selected: 0
NCT IDTitle
NCT04050085SD-101, Nivolumab, and Radiation Therapy in Treating Patients With Chemotherapy-Refractory Metastatic Pancreatic Cancer
NCT00399685Drug Interaction - Oral Contraceptive
NCT06045689A Study to Assess Luspatercept in Lower-risk Myelodysplastic Syndrome Participants
NCT07226817A Study to Assess the Relative Bioavailability of BMS-986435 and Food Effect on the BMS-986435 in Healthy Adult Participants
NCT00198289Aurexis® in Cystic Fibrosis Subjects Chronically Colonized With Staphylococcus Aureus in Their Lungs
NCT00251485A Phase II Trial of Modified FOLFOX 6 and Cetuximab in First Line Treatment of Metastatic Colorectal Cancer
NCT01454115Study to Evaluate the Safety, Pharmacokinetics and Tolerability of BMS-708163
NCT00410410A Study of Abatacept in Patients With Active Ulcerative Colitis
NCT00272779BMS-Reyataz Study in Treatment in Naive Subjects to Compare the Efficacy and Safety Between Boosted Reyataz and Kaletra When in Combination With Fixed Dose Truvada
NCT02632409An Investigational Immuno-therapy Study of Nivolumab, Compared to Placebo, in Patients With Bladder or Upper Urinary Tract Cancer, Following Surgery to Remove the Cancer
NCT03639714A Study of a Personalized Neoantigen Cancer Vaccine
NCT04141644Safety and Efficacy of Combination Osimertinib and Ipilimumab in Patients w EGFR Mutated NSCLC
NCT01452334Safety Study of Anti-Programmed Death-Ligand 1 in Hematologic Malignancy
NCT00724334A Long-Term Study of the Effects of Orally Administered SAR302503 in Patients With Myelofibrosis
NCT00798252Ascending Multiple-Dose Study of Brivanib Alaninate in Combination With Chemotherapeutic Agents in Subjects With Advanced Cancers
NCT00162214Study of Dasatinib in Patients With Advanced Solid Tumors
NCT04080804Study of Safety and Tolerability of Nivolumab Treatment Alone or in Combination With Relatlimab or Ipilimumab in Head and Neck Cancer
NCT00024284Carboplatin and Irinotecan in Treating Children With Refractory Solid Tumors
NCT00282139Aripiprazole in the Treatment of Tourette's Syndrome
NCT01866930Efficacy and Safety Study of Pegylated Interferon Lambda-1a With Ribavirin and Daclatasvir, to Treat naïve Subjects With Chronic HCV Genotypes 1, 2, 3, and 4 Who Are Co-infected With HIV
NCT01587365Single Ascending Dose Safety Study of BMS-962476 in Healthy Subjects and Patients With Elevated Cholesterol on Statins
NCT00940771Equivalence of Boosted Atazanavir Based Regimens and Currently Effective HAART Regimens
NCT01968109An Investigational Immuno-therapy Study to Assess the Safety, Tolerability and Effectiveness of Anti-LAG-3 With and Without Anti-PD-1 in the Treatment of Solid Tumors
NCT01063036Efficacy and Safety Study of Entecavir Plus Tenofovir in Patients With Chronic Hepatitis B Who Failed Previous Treatment
NCT00971867Rollover Study of Weekly Paclitaxel (BMS-181339) in Patients With Head and Neck Cancer
NCT04969887Combination Immunotherapy in Rare Cancers Under InvesTigation
NCT01605084Second-line Treatment of HIV-1 With Ritonavir Boosted Atazanavir or Darunavir With an Optimized NRTI Backbone
NCT07225647A Study to Assess the Effect of Food on the Drug Levels of Admilparant
NCT04584307Phase II Study of Immunomaintenance Using POmalidomide With Elotuzumab afteR Second Autologous Transplant
NCT03651271Nivolumab With or Without Ipilimumab in Advanced Metastatic Cancer
NCT06951698A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder
NCT04477512Cabozantinib and Abiraterone With Checkpoint Inhibitor Immunotherapy in Metastatic Hormone Sensitive Prostate Cancer (CABIOS Trial)
NCT05213312Study of Neoadjuvant Nivolumab or Placebo Plus Chemotherapy Followed by Surgery and Adjuvant Treatment in Subjects With Resectable ESCC
NCT06050512Mezigdomide Plus Ixazomib and Dexamethasone for Relapsed and Refractory Multiple Myeloma
NCT03726281Nivolumab in Platinum Recurrent or Refractory Metastatic Germ Cell Tumors
NCT03421652Nivolumab and RT in Treating Patients With Localized/Locally Advanced Urothelial Bladder Cancer Ineligible for Chemo
NCT01006603Saxagliptin Compared to Glimepiride in Elderly Type 2 Diabetes Patients, With Inadequate Glycemic Control on Metformin
NCT00000822A Phase I/II Double-Blind Controlled Trial to Determine the Safety and Immunogenicity of HIV-1 MN rgp160 Immuno AG Vaccine Therapy in HIV-Infected Individuals With Greater Than or Equal to 500/mm3 CD4+ T Cells and 200-400/mm3 CD4+ T Cells
NCT00165334Cetuximab and Vinorelbine in Elderly Subjects With Lung Cancer
NCT00501644Chemoimmunotherapy Study for Patients With Epithelial Ovarian Cancer
NCT01217892Evaluation of Dapagliflozin Taken Twice-daily
NCT00481247A Phase III Study of Dasatinib vs Imatinib in Patients With Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia
NCT00560352Safety Study of Dasatinib With Bortezomib (Velcade®) and Dexamethasone for Multiple Myeloma
NCT06708949A Randomized Phase 2 Trial of Nivolumab, Relatlimab Plus Ipilimumab vs. Nivolumab Plus Ipilimumab in First-line Advanced Renal Cell Carcinoma (RCC)
NCT03515655A Study of Patients Hospitalized With Acute Heart Failure With Reduced Ejection Fraction (HFrEF)
NCT06297226Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma
NCT01654692A Combination of Ipilimumab and Fotemustine for Treat Unresectable Locally Advanced or Metastatic Melanoma
NCT02922452A Study to Evaluate the Effect of Diltiazem on the Pharmacokinetics (PK) of BMS-986141 in Healthy Subjects
NCT06248814A Study to Evaluate the Safety, Tolerability, Drug Levels, and Drug Effects of BMS-986326 in Participants With Atopic Dermatitis
NCT03508258Study to Describe Risk of Bleeding in Patients Depending on the Different Anticoagulant Therapy They Are on for Atrial Fibrillation (AF)